Product Information
GENOTROPIN 5 MG CARTRIDGE is a brand product labeled by Pfizer Inc., priced at $752.2240 per EA under NDC 00013262681. Its NADAC has been published 671 times since Nov 28, 2013.
Manufacturer
Pfizer Inc.NDC
00013262681
Classification
Brand
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Biologic (BLA)
FDA Application
BLA020280On Market Since
12/20/1995
Price Statistics
The NADAC for GENOTROPIN 5 MG CARTRIDGE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 84.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $752.2240 per EA |
|---|---|
| All-time high | $752.2240 (Sep 30, 2026) |
| All-time low | $408.5277 (Nov 28, 2013) |
| 52-week high | $752.2240 |
| 52-week low | $726.5500 |
| Median price | $639.5768 |
| Average price | $613.3043 |
| Largest weekly change | +9.4% (Jan 7, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
somatropin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GENOTROPIN 5 MG CARTRIDGE?
The current National Average Drug Acquisition Cost (NADAC) for GENOTROPIN 5 MG CARTRIDGE, manufactured by Pfizer Inc., is $752.2240 per EA (NDC 00013262681), effective Sep 30, 2026.
How has the price of GENOTROPIN 5 MG CARTRIDGE changed over time?
Over the history we have for it, the NADAC for GENOTROPIN 5 MG CARTRIDGE has risen 84.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GENOTROPIN 5 MG CARTRIDGE?
Since Nov 28, 2013, the NADAC for GENOTROPIN 5 MG CARTRIDGE has ranged from a low of $408.5277 (Nov 28, 2013) to a high of $752.2240 (Sep 30, 2026), with a median of $639.5768 per EA.
Are there cheaper alternatives to GENOTROPIN 5 MG CARTRIDGE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GENOTROPIN MINIQUICK 0.2 MG, is $30.8987 per EA — about 96% below GENOTROPIN 5 MG CARTRIDGE.
Who manufactures GENOTROPIN 5 MG CARTRIDGE?
GENOTROPIN 5 MG CARTRIDGE (NDC 00013262681) is labeled by Pfizer Inc., and CMS classifies it as a brand product.